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NR4A1 Deletion in Marginal Zone B Cells 
Exacerbates Atherosclerosis in Mice—Brief Report
Meritxell Nus , Gemma Basatemur , Maria Galan , Laia Cros-Brunsó , Tian X. Zhao , Leanne Masters, James Harrison, 
Nichola Figg, Dimitrios Tsiantoulas , Frederic Geissmann, Christoph J. Binder , Andrew P. Sage , Ziad Mallat
OBJECTIVE: NR4A orphan receptors have been well studied in vascular and myeloid cells where they play important roles in the 
regulation of inflammation in atherosclerosis. NR4A1 (nerve growth factor IB) is among the most highly induced transcription 
factors in B cells following BCR (B-cell receptor) stimulation. Given that B cells substantially contribute to the development 
of atherosclerosis, we examined whether NR4A1 regulates B-cell function during atherogenesis.
APPROACH AND RESULTS: We found that feeding Ldlr−/− mice a Western diet substantially increased Nr4a1 expression in marginal 
zone B (MZB) cells compared with follicular B cells. We then generated Ldlr−/− mice with complete B- or specific MZB-cell deletion 
of Nr4a1. Complete B-cell deletion of Nr4a1 led to increased atherosclerosis, which was accompanied by increased T follicular 
helper cell–germinal center axis response, as well as increased serum total cholesterol and triglycerides levels. Interestingly, 
specific MZB-cell deletion of Nr4a1 increased atherosclerosis in association with an increased T follicular helper–germinal 
center response but without any impact on serum cholesterol or triglyceride levels. Nr4a1−/− MZB cells showed decreased 
PDL1 (programmed death ligand-1) expression, which may have contributed to the enhanced T follicular helper response.
CONCLUSIONS: Our findings reveal a previously unsuspected role for NR4A1 in the atheroprotective role of MZB cells.
GRAPHIC ABSTRACT: A graphic abstract is available for this article.
Key Words: animals ◼ atherosclerosis ◼ cholesterol ◼ diet, Western ◼ mice
Atherosclerosis is a chronic inflammatory disease involving interactions between vascular, circulating, and immune cells. B cells play an important role in the 
chronic immunoinflammatory response, producing antibod-
ies and regulating T-cell and natural killer–cell activation. 
The role of B cells in atherosclerosis is complex, with ath-
erogenic and protective roles assigned for distinct B-cell 
subsets.1 B2 cells comprise the phenotypically distinct fol-
licular B (FOB) cells of the spleen and the lymph nodes 
and the marginal zone B (MZB) cell population of the 
spleen. While depletion of all B2 cells reduces atheroscle-
rosis,2–4 we have recently discovered that selective deple-
tion of MZB cells promotes atherosclerosis.5 In response 
to a high-fat/high-cholesterol (HF/HC) diet, MZB cells 
activate an atheroprotective programme, limiting T follicu-
lar helper (Tfh) cell motility in a PDL1 (programmed death 
ligand-1)-dependent manner.5
NR4A1 (nerve growth factor IB; also called Nur77) 
is a member of the NR4A orphan nuclear receptor sub-
family. NR4A1 has been involved in negative selection 
of thymocytes, differentiation of regulatory T cells, and 
development of Ly6C− monocytes.6 However, little is 
known about its role in B cells besides the fact that it 
is rapidly induced upon BCR (B-cell receptor) signal-
ing activation7 and that it may regulate the survival of 
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complex roles in atherosclerosis, at least in part, due to 
its impact on vascular cell,9 monocyte,6,10,11 and T-cell biol-
ogy.6,12 We have now addressed the role of NR4A1 spe-
cifically in B cells in the development of atherosclerosis.
MATERIALS AND METHODS
The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
Animals
All experiments were approved by the Home Office, United 
Kingdom, and were performed under Personal Project Licence 
80/2426. All mice were on C57Bl/6J background. Cd79aCre/+, 
µMT, Nr4a1−/−, and Ldlr–/– mice were originally from The Jackson 
Laboratory. Rbpjkflox/flox mice were kindly provided by Tasuku 
Honjo.13 To generate an atherosclerotic mouse model that lacks 
MZB cells, Cd79aCre/+; Rbpjkflox/flox were crossed with Ldlr–/– to 
generate Ldlr−/−; Cd79aCre/+; RBPflox/flox mice. For atherosclerosis 
experiments, we generated 2 different mice models. For dele-
tion of Nr4a1 in all B cells, 6- to 8-week-old Ldlr–/– mice were 
lethally irradiated (two 5.5 Gy fractioned doses) and injected 
with a mixed bone marrow (BM) chimera containing 80% uMT 
plus either 20% WT (wild type) C57Bl/6J (to reconstitute with 
WT B cells) or 20% Nr4a1−/− (to reconstitute with Nr4a1−/− B 
cells). We only used male mice to limit the number of animals 
used in our experiments. In subsequent experiments, we used 
both males and females. For deletion of Nr4a1 selectively in 
MZB cells, we developed a partial irradiation model in athero-
sclerotic mice lacking MZB cells. Recipient Ldlr−/−; Cd79aCre/+; 
RBPflox/flox male and female mice were partially irradiated (1 
single dose of 4 Gy) and injected intravenously with BM from 
Nr4a1−/− or WT C57Bl/6J male and female mice, respectively, 
which we expected to result in reconstitution of MZB cell com-
partment with cells coming from the donors (Nr4a1−/− or WT), 
while the rest of immune cells (including FOB, T, myeloid, etc) 
would be mostly from the recipient. To validate this partial irra-
diation model, we used the CD45 (cluster of differentiation 
45) congenic lineage tracing system. We exposed recipient 
CD45.2+; CD45.1− male and female mice lacking MZB cells 
(LDLr−/−; Cd79a Cre/+; RBPflox/flox) to different doses of irradia-
tion (from 4 to 7 Gy), then injected CD45.2−; CD45.1+ male 
and female BM donor cells, respectively, to allow us to track the 
reconstitution of B-cell subsets using flow cytometry. A single 
dose of 4 Gy resulted in reconstitution of the majority of MZB 
cells (>99%) with donor CD45.2−; CD45.1+ cells, while the 
majority of the FOB cells and the rest of the BM-derived cells 
(including other lymphocytes [FSClow] and myeloid [FSChi] cells; 
90%) were from the CD45.2+; CD45.1− recipient (Figure I in 
the Data Supplement).
For atherosclerotic experiments, all recipient mice were ran-
domly assigned to different experimental groups based on their 
weight at the beginning of the experiment. After 6 weeks of 
recovery, mice were started on HF/HC (21% fat, 0.15% cho-
lesterol) for 8 weeks.
Extent and Composition of Atherosclerotic 
Lesions
The lesions in the root of the aorta beneath all 3-valve leaf-
lets were analyzed. To measure atherosclerotic plaque size, 
we stained paraffin-embeded sections with Masson trichrome. 
To characterize atherosclerotic lesion composition, we stained 
sections for macrophages (Mac-3 [lysosome-associated mem-
brane protein 2], 1:200, clone M3/84; Santa Cruz), T cells (poly-
clonal CD3, 1:100; Dako), and neutrophils (Ly6G [lymphocyte 
antigen 6 complex locus G6D], 1:100, clone 1AB; BD). We 
performed each staining on a single slide (3 sections for each 
staining) from approximately the same level of the aortic root for 
all experimental and control mice. Computer-assisted analysis 
(Image-J) was used to determine lesion size and areas or cell 
counts for specific cell types. All slides for each experiment were 
analyzed by the same blinded observer to minimize variations. All 
measurements were performed by manual selection of stained 
pixel thresholds and presented as percent positive (stained) 
area relative to the entire intimal area. CD4+ T and Ly6G+ cells 
were counted, and the data are presented as the number of T 
cells per total number of cells or as the total number of cells 
per section, respectively, in atherosclerotic plaques and adventi-
tia. Representative images of immunofluorescence staining are 
included in Figure II in the Data Supplement. Whole aortas were 
prepared en face for Oil Red O staining to measure lipid deposi-
tion and quantification of lesion size using J-Microvision.
Flow Cytometry
Single-cell suspensions of homogenized spleen and inguinal 
lymph nodes were stained with fluorophore-conjugated antibod-
ies and analyzed using an LSRII Fortessa (Becton, Dickinson and 
Company) or FACSCantoII (BD) flow cytometer as described pre-
viously.5 Representative plots of gating strategies can be found in 
Figure II in the Data Supplement.






LDLR low-density lipoprotein receptor
MZB marginal zone B
Tfh T follicular helper
WT wild type
Highlights
• NR4A1 is a new target that modulates B-cell func-
tions in atherosclerosis.
• Nr4a1 deletion in B2 cells increases atherosclerosis 
and is associated with increased Tfh-GC response 
and circulating lipid levels.
• NR4A1 expression in MZB cells regulates PDL1 
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Determination of Circulating Antibodies
Specific antibody titers to given antigens in plasma were deter-
mined by chemiluminescent ELISA as described previously.14,15
Determination of Serum Lipid Levels
Total cholesterol, triglycerides, and HDL-C were measured by 
an enzymatic method in a Siemens Dimensions RxL analyzer.
Purification of MZB and FOB
Single-cell suspensions were prepared from spleens by dis-
sociation through 70-µm filters using a syringe plunger. For 
MZB and FOB cell purification, B cell–enriched populations 
were separated by Automacs using a B-cell purification kit 
(Miltenyi Biotech), and B cells were stained for 15 minutes at 
4°C with anti-CD23-phycoerythrine and anti-CD21-fluores-
cein isothiocyanate. After washing and staining with 7-AAD for 
cell viability, MZB (CD21hiCD23low) and FOB (CD23hiCD21low) 
were sorted using an AriaIII Cell, Influx, or FACSJazz sorter 
(BD). Purity of both populations was higher than 95%.
BCR Stimulation
Purified sorted MZB and FOB from WT or Nr4a1−/− mice were 
stimulated for 30 minutes, 3 hours, or 6 hours with F(ab)2 frag-
ment of the anti-IgM (eBioscience; 10 ug/mL).
Quantitative Real-Time Polymerase Chain 
Reaction
For gene expression analysis, RNA from sorted MZB and 
FOB cells was isolated using RNAeasy mini kit (Qiagen). qRT-
PCR was performed using Quantitect whole transcriptome kit. 
qRT-PCR was performed with SYBR-green primers. Primer 
sequences are listed in Table I in the Data Supplement.
Statistical Analysis
Values are expressed as means±SEM. Based on pilot experi-
ments, we found that MZB deficiency increases lesion size by 
2-fold. Use of the equation for Student t test for the difference 
of 2 means gives us an n=6 to detect a 50% increase in lesion 
size with α=0.05 and 90% power. Where data sets passed nor-
mality tests, differences between values were examined using 
parametric 2-tailed unpaired Student t test, other data sets by 
using nonparametric Mann-Whitney U test; and were considered 
significant at P<0.05 for the B-cell model where only males were 
used. In the partial irradiation model, we used both males and 
females and performed 2-way ANOVA to determine comparisons 
between genotypes. When sex did not have a significant effect on 
the results, we pooled the male and female data. When sex had a 
significant effect, data were not pooled, and Bonferroni post hoc 
analysis was performed to find differences between groups.
RESULTS
NR4A1 Deletion in B Cells Exacerbates 
Atherosclerosis
We reconstituted lethally irradiated Ldlr−/− male mice 
with a mixed BM containing 80% of BM cells from µMT 
male mice (which cannot produce B cells) supplemented 
with either 20% BM from WT C57Bl/6J mice (referred 
to as the WT B-cell group) or 20% of BM cells from 
Nr4a1−/− mice (referred to as the Nr4a1−/− B-cell group). 
MZB and FOB cells were reconstituted equally in both 
groups (Figure III in the Data Supplement). After recov-
ery, mice were put on a high-fat/high-cholesterol diet 
for 8 weeks. Specific Nr4a1 deletion in B cells mark-
edly accelerated the development of atherosclerosis in 
the aortic sinus (Figure 1A) and the aortic arch (Figure 
III in the Data Supplement). Serum levels of total choles-
terol and triglycerides were also significantly increased 
in the Nr4a1−/− B-cell group (Figure 1B through 1D), 
which could account, at least in part, for the increased 
atherosclerosis seen in these mice. Analysis of plaque 
composition showed a trend toward increased %necrotic 
core area but a similar percentage of macrophages and 
CD3+ T cells in lesions of Nr4a1−/− compared with WT 
B-cell mice (Figure III in the Data Supplement). In the 
adventitia, we found similar percentages of CD3+ T cells 
and a trend toward increased percentages of neutrophils 
(Ly6G+) in the Nr4a1−/− compared with WT B-cell mice 
(Figure III in the Data Supplement). We did not find any 
difference in blood immune cell subsets (including B 
cells, T cells, neutrophils, and monocytes) between both 
groups (Figure III in the Data Supplement).
We then characterized the innate and the adaptive 
immune responses in the spleen. Splenic dendritic cell, 
monocyte, and neutrophil levels were similar between 
the 2 groups of mice (Figure III in the Data Supplement). 
Nr4a1−/− B-cell mice showed a trend toward increased Tfh 
cell numbers (P=0.07) and had significantly increased ger-
minal center (GC) B cells (P<0.05) compared with mice 
with WT B cells (Figure 1E and 1F). All other T-cell subsets 
including T effector memory, T regulatory cells, and T follic-
ular regulatory cells were not significantly altered between 
the two groups (Figure IV in the Data Supplement).
We have previously demonstrated that B2 cells play 
different roles in atherosclerosis, with MZB cells being 
atheroprotective through limitation of Tfh cell formation 
(MZB cell deletion leads to increased Tfh)5—a pheno-
type that is similar to the present phenotype observed 
for B cell–specific depletion of Nr4a1−/−. Furthermore, 
expression of Nr4a1 was significantly upregulated in 
purified MZB cells but downregulated in FOB cells from 
LDLr−/− mice consuming a high-fat/high-cholesterol diet, 
in comparison with mice fed a standard laboratory diet 
(Figure 1G). Therefore, we addressed the role of NR4A1 
specifically in MZB cells during the development of 
atherosclerosis.
NR4A1 Deletion Selectively in MZB Cells 
Exacerbates Atherosclerosis
To study the role of Nr4a1 in MZB cells and its impact 
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mouse model in which Nr4a1−/− was specifically deleted 
in MZB cells. For this aim, we generated Ldlr−/− mice 
on Cd79aCre/+; RBPflox/flox background (mice that do not 
have MZB cells, as described previously5). After partial 
irradiation (4 Gy), Ldlr−/−; Cd79aCre/+; RBPflox/flox male and 
female mice were injected with WT or Nr4a1−/− BM from 
males and females, respectively, resulting in mice recon-
stituted with WT MZB cells (the WT MZB cell group) or 
with MZB cells in which Nr4a1 has been deleted (the 
Nr4a1−/− MZB cell group; see Materials and Methods 
section for a more detailed explanation of the model and 
Figure I in the Data Supplement). Both groups had the 
Figure 1. Nr4a1 (nerve growth factor IB) deletion in B cells increases atherosclerosis development.
Ldlr−/− mice were transplanted with a mixed chimera containing 80% µMT +20% WT (wild type; for reconstitution with WT B cells) or 20% 
Nr4a1−/− (for reconstitution with Nr4a1−/− B cells) BM and fed a high-fat/high-cholesterol (HF/HC) diet for 8 wk (A–F). A, Representative 
Masson trichrome staining and quantification of atherosclerotic plaques in aortic roots (each symbol represents one mouse, and the horizontal 
bars are group mean±SEM with n=7 and n=9, respectively, in each group). Original magnification, ×10. Scale bars=500 μm. B–D, Total 
plasma cholesterol, triglycerides, and HDL (high-density lipoprotein) cholesterol levels. E and F, Total numbers of T follicular helper (Tfh) cells 
(CD3+ CD4+ CD44+ CD62L− ICOS+ CXCR5+ PD1+) and germinal center (GC) B cells (B220+ CD19+ CD95+ GL7+; n=13–15 in each 
group). G, Nr4a1 relative expression in sorted marginal zone B (MZB) and follicular B (FOB) cells from Ldlr−/− mice fed a standard laboratory 
or HF/HC diet for 8 wk (n=3–4 in each group). For A–G, 2-tailed unpaired Student t test or 2-way ANOVA followed by Bonferroni post hoc 
analysis, *P<0.05 and ***P<0.001. CD indicates cluster of differentiation; CXCR5, C-X-C chemokyne receptor-5; ICOS, inducible T-cell 
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same numbers of MZB and FOB cells after reconstitu-
tion (Figure I in the Data Supplement).
After 8 weeks on a high-fat/high-cholesterol diet, 
deletion of Nr4a1 specifically in MZB cells led to 
increased development of atherosclerosis in the aor-
tic sinus (Figure 2A) and increased lipid deposition in 
the aortic arches (Figure V in the Data Supplement), 
without altering serum levels of total cholesterol, HDL-
C, or triglycerides, compared with mice with WT MZB 
cells (Figure 2B through 2D). Females had increased 
atherosclerotic plaques and decreased HDL-C levels 
than males—a phenotype that has been reported pre-
viously in LDLr−/− mice.16 Analysis of plaque composi-
tion showed a trend toward increased %necrotic core 
area in the Nr4a1−/− MZB cell group while there were 
no differences in percentages of Mac-3+ macrophages 
and CD3+ T cells between both groups (Figure V in 
the Data Supplement). No significant differences were 
found in the percentages of CD3+ T cells and neutro-
phils in the adventitia between the 2 groups (Figure V 
in the Data Supplement).
Interestingly, Nr4a1−/− MZB-cell mice had signifi-
cantly increased splenic Tfh and GC B-cell numbers 
(Figure 2E and 2F) compared with WT MZB-cell mice, 
without detectable changes in serum antibody titers 
against modified LDL (low-density lipoprotein; Figure 
V in the Data Supplement). Despite our limitations 
to comprehensively assess the antibody response, 
we hypothesize that other Tfh cell functions may 
account for their atherogenic role, as discussed previ-
ously.5 Nr4a1−/− MZB cell group also had significantly 
increased T regulatory cells and T follicular regulatory 
CD25pos cells, while T effector memory, T follicular reg-
ulatory CD25neg cells, dendritic cells, neutrophils, and 
monocytes were not significantly altered (Figure VI in 
the Data Supplement).
NR4A1 Regulates PDL1 Expression
We found that MZB cells from the Nr4a1−/− MZB group 
expressed lower levels of the PDL1 encoding gene 
(Cd274) and PDL1 protein (Figure 2G and 2H) com-
pared with those from the WT MZB group, which could, 
at least in part, explain why the Nr4a1−/− MZB cell group 
also showed increased Tfh cells.5
To further examine the link between NR4A1 and 
PDL1, we performed in vitro experiments using sorted 
MZB cells from total WT and Nr4a1−/− mice. MZB cells 
from Nr4a1−/− mice expressed lower levels of PDL1 than 
WT MZB cells at baseline (Figure VII in the Data Supple-
ment). As described previously, Nr4a117 and Cd2745 sig-
nificantly increased upon BCR activation (Figure VII in 
the Data Supplement). BCR-induced pBTK (Bruton tyro-
sine kinase) was not altered in the absence of NR4A1 
(Figure VII in the Data Supplement). BCR-induced 
Cd274 gene expression was significantly downregulated 
in the absence of NR4A1 (Figure VII in the Data Supple-
ment). However, BCR-mediated regulation of MZB cell 
surface PDL1 protein expression was not altered in the 
absence of NR4A1 (Figure VII in the Data Supplement). 
These data suggest that the impact of NR4A1 deletion 
on PDL1 expression in vivo was independent of BCR 
activation.
DISCUSSION
To the best of our knowledge, this is the first experimen-
tal study addressing the role of NR4A1 in B cells during 
atherosclerosis. Our data show that NR4A1 expression 
in MZB cells regulates PDL1 expression, limiting the 
Tfh-GC response and protecting from atherosclerosis. A 
recent work performed in a cancer line has shown that 
NR4A1 binds to the GC motif of the PDL1 promoter and 
regulates its gene expression,18 further supporting the 
possibility of a direct regulation of PDL1 expression by 
NR4A1 in MZB cells. Previous studies suggested that 
PDL1 expression in antigen-presenting cells might limit 
proatherogenic immune responses.19 Whether NR4A1 
also regulates PDL1 expression in immune cells, other 
than MZB cells, is worth of investigation.
Interestingly, NR4A1 may regulate PDL1 in a BCR-
independent manner, opening up an opportunity to 
modulate NR4A1-dependent pathways in B cells with-
out affecting the BCR signaling pathway. Furthermore, 
human MZB-like cells express high levels of NR4A120 
and PDL1,5 and, therefore, we speculate that NR4A1 
may have a similar role in human B cells, although further 
studies are required to determine whether this is indeed 
the case. The potential use of Bis-Indole-NR4A1 antag-
onists as anticancer treatments is starting to emerge,18,21 
and, therefore, we would advise to take into consider-
ation their effect on B cells to avoid or monitor potential 
undesirable cardiovascular side effects associated to 
anticancer treatments.
NR4A1 has previously been reported to play a very 
important role in B-cell survival.8,22 Nevertheless, in both 
of our B-cell models of Nr4a1 deletion, we did not find 
any difference in B-cell numbers, making it unlikely that 
NR4A1 regulates B-cell survival during atherosclerosis. 
This is in agreement with a recent finding that NR4A1 
regulates B-cell survival in a T cell–independent response 
but not in a T cell–dependent response.23 In our models, 
we could not study the potential contribution of NR4A1 
in B1 cells because these cells do not reconstitute well 
after irradiation, and, therefore, further experiments are 
needed to elucidate the role of NR4A1 in B1 cells during 
atherosclerosis.
Surprisingly, NR4A1 deletion in all B2 cells not only 
regulates the Tfh-GC response but also the circulating 
lipid levels. Thus, B2 cells other than MZB cells could 
be responsible for this effect on lipid parameters. B cells 
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CD1d, and scavenger receptors, that could recognize 
and remove lipids.24 Moreover, previous studies modulat-
ing B cells have shown changes in cholesterol levels,25,26 
but none of the previous atherosclerotic models target-
ing NRA1 in monocytes have shown a significant effect 
on lipid levels.10,11 Thus, the specific role of B cells in lipid 
Figure 2. Nr4a1 (nerve growth factor IB) deletion in marginal zone B (MZB) cells increases atherosclerosis development.
Ldlr−/−; Cd79aCre/+; Rbpjkflox/flox were partially irradiated (Materials and Methods in the Data Supplement) and transplanted with WT (wild type; 
for reconstitution with WT MZB cells) or Nr4a1−/− (for reconstitution with Nr4a1−/− MZB cells) BM and fed a high-fat/high-cholesterol diet for 8 
wk (A–H). A, Representative Masson trichrome staining and quantification of atherosclerotic plaques in aortic roots (each symbol represents 
one mouse, and horizontal bars are group mean±SEM with n=16–18 in each group). Original magnification, ×10. Scale bars=500 μm. B–D, 
Total plasma cholesterol, HDL (high-density lipoprotein) cholesterol, and triglycerides levels. E and F, Total numbers of T follicular helper (Tfh) 
and germinal center (GC) B cells. Cd274 (Pdl1 [programmed death ligand-1] gene) expression, quantified by qRT-PCR (n=5 in each group) 
in sorted MZB cells (G) and PDL1 protein expression, quantified by flow cytometry in splenic MZB cells (H; n=16–18 in each group). For 
A–G, 2-tailed unpaired Student t test or 2-way ANOVA followed by Bonferroni post hoc analysis, *P<0.05 and **P<0.01. MFI indicates mean 
















Nus et al B-Cell NR4A1 in Atherosclerosis
2604  November 2020 Arterioscler Thromb Vasc Biol. 2020;40:2598–2604. DOI: 10.1161/ATVBAHA.120.314607
metabolism is yet to be clarified, and further experiments 
are required.
Overall, our data demonstrate that NR4A1 in B cells 
is an attractive target to modulate the development of 
atherosclerotic disease.
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